UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins

Proceedings of the National Academy of Sciences - PNAS, 2012-11, Vol.109 (47), p.19408-19413

2012

Volltextzugriff (PDF)

Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance

Proceedings of the National Academy of Sciences - PNAS, 2019-05, Vol.116 (19), p.9433-9442

2019

Volltextzugriff (PDF)

Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway

PloS one, 2016-11, Vol.11 (11), p.e0166363-e0166363

2016

Volltextzugriff (PDF)

Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14-mutant Non-small Cell Lung Cancer

Clinical cancer research, 2019-02, Vol.25 (4), p.1248-1260

2019

Volltextzugriff (PDF)

Uncovering molecular features driving lung adenocarcinoma heterogeneity in patients who formerly smoked

Journal of translational medicine, 2024-07, Vol.22 (1), p.634-14, Article 634

2024

Volltextzugriff (PDF)

New insights into the biology and development of lung cancer in never smokers-implications for early detection and treatment

Journal of translational medicine, 2023-08, Vol.21 (1), p.585-16, Article 585

2023

Volltextzugriff (PDF)

Response to ERBB3-Directed Targeted Therapy in NRG1 -Rearranged Cancers

Cancer discovery, 2018-06, Vol.8 (6), p.686-695

2018

Volltextzugriff (PDF)

Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research

JNCI : Journal of the National Cancer Institute, 2010-09, Vol.102 (17), p.1310-1321

2010

Volltextzugriff (PDF)

Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells

eLife, 2018-11, Vol.7

2018

Volltextzugriff (PDF)

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells

PloS one, 2009-10, Vol.4 (10), p.e7464-e7464

2009

Volltextzugriff (PDF)

Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models

Cancer cell, 2011-09, Vol.20 (3), p.289-299

2011

Volltextzugriff (PDF)

Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma

eLife, 2015-06, Vol.4, p.e06907-e06907

2015

Volltextzugriff (PDF)

Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma

Nature communications, 2019-11, Vol.10 (1), p.5438-13, Article 5438

2019

Volltextzugriff (PDF)

PIK3CA Mutations and Copy Number Gains in Human Lung Cancers

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (17), p.6913-6921

2008

Volltextzugriff (PDF)

Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines

Proceedings of the National Academy of Sciences - PNAS, 2011-09, Vol.108 (39), p.16375-16380

2011

Volltextzugriff (PDF)

Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4

Oncogenesis (New York, NY), 2021-03, Vol.10 (3), p.27-27, Article 27

2021

Volltextzugriff (PDF)

Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer

eLife, 2021-06, Vol.10

2021

Volltextzugriff (PDF)

Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines

PloS one, 2009-02, Vol.4 (2), p.e4576-e4576

2009

Volltextzugriff (PDF)

Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability

PloS one, 2012-03, Vol.7 (3), p.e33003-e33003

2012

Volltextzugriff (PDF)

Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells

Cell reports (Cambridge), 2022-02, Vol.38 (6), p.110343-110343, Article 110343

2022

Volltextzugriff (PDF)

Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1

Proceedings of the National Academy of Sciences - PNAS, 2012-01, Vol.109 (3), p.E119-E126

2012

Volltextzugriff (PDF)

Delineating spatial cell-cell interactions in the solid tumour microenvironment through the lens of highly multiplexed imaging

Frontiers in immunology, 2023-10, Vol.14, p.1275890-1275890

2023

Volltextzugriff (PDF)

CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development

Oncoimmunology, 2022-01, Vol.11 (1), p.2010905-2010905

2022

Volltextzugriff (PDF)

MIR155 Regulation of Ubiquilin1 and Ubiquilin2: Implications in Cellular Protection and Tumorigenesis

Neoplasia (New York, N.Y.), 2017-04, Vol.19 (4), p.321-332

2017

Volltextzugriff (PDF)

Characterizing the secretome of EGFR mutant lung adenocarcinoma

Frontiers in oncology, 2024-01, Vol.13, p.1286821

2024

Volltextzugriff (PDF)

1 – 25 von 427

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(289)
Mit Volltextzugriff
(378)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(427)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins

Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance

Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway

Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14-mutant Non-small Cell Lung Cancer

Uncovering molecular features driving lung adenocarcinoma heterogeneity in patients who formerly smoked

New insights into the biology and development of lung cancer in never smokers-implications for early detection and treatment

Response to ERBB3-Directed Targeted Therapy in NRG1 -Rearranged Cancers

Lung Cancer Cell Lines as Tools for Biomedical Discovery and Research

Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells

Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models

Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma

Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma

PIK3CA Mutations and Copy Number Gains in Human Lung Cancers

Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines

Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4

Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer

Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines

Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability

Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells

Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1

Delineating spatial cell-cell interactions in the solid tumour microenvironment through the lens of highly multiplexed imaging

CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development

MIR155 Regulation of Ubiquilin1 and Ubiquilin2: Implications in Cellular Protection and Tumorigenesis

Characterizing the secretome of EGFR mutant lung adenocarcinoma

Suchergebnisse filtern